VKTX
Viking Therapeutics Inc
NASDAQ: VKTX · HEALTHCARE · BIOTECHNOLOGY
$30.00
-3.78% today
Updated 2026-05-01
Market cap
$3.63B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$23 – $43
Volume
2.4M
Viking Therapeutics Inc (VKTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |